Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 10,000 shares of the stock in a transaction that occurred on Tuesday, September 13th. The stock was purchased at an average price of $9.95 per share, for a total transaction of $99,500.00. Following the acquisition, the chief executive officer now owns 3,068,951 shares in the company, valued at $30,536,062.45. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Monday, September 12th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The stock was purchased at an average price of $9.79 per share, for a total transaction of $97,900.00.
  • On Friday, September 9th, Phillip Md Et Al Frost purchased 3,600 shares of Opko Health stock. The stock was purchased at an average price of $9.87 per share, for a total transaction of $35,532.00.
  • On Friday, September 2nd, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The stock was purchased at an average price of $9.28 per share, for a total transaction of $92,800.00.
  • On Thursday, August 25th, Phillip Md Et Al Frost purchased 48,400 shares of Opko Health stock. The stock was purchased at an average price of $9.06 per share, for a total transaction of $438,504.00.
  • On Wednesday, August 24th, Phillip Md Et Al Frost purchased 15,000 shares of Opko Health stock. The stock was purchased at an average price of $9.24 per share, for a total transaction of $138,600.00.
  • On Tuesday, August 23rd, Phillip Md Et Al Frost purchased 29,000 shares of Opko Health stock. The stock was purchased at an average price of $9.53 per share, for a total transaction of $276,370.00.
  • On Monday, August 22nd, Phillip Md Et Al Frost purchased 11,800 shares of Opko Health stock. The stock was purchased at an average price of $9.76 per share, for a total transaction of $115,168.00.
  • On Friday, August 19th, Phillip Md Et Al Frost purchased 15,000 shares of Opko Health stock. The stock was purchased at an average price of $9.82 per share, for a total transaction of $147,300.00.
  • On Thursday, August 18th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The stock was purchased at an average price of $9.87 per share, for a total transaction of $98,700.00.
  • On Wednesday, August 17th, Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock. The shares were bought at an average price of $9.90 per share, for a total transaction of $99,000.00.

Opko Health Inc. (NYSE:OPK) opened at 10.21 on Monday. The firm’s 50 day moving average price is $9.75 and its 200-day moving average price is $10.05. The stock has a market cap of $5.62 billion and a price-to-earnings ratio of 42.72. Opko Health Inc. has a 52 week low of $7.12 and a 52 week high of $11.85.

Opko Health (NYSE:OPK) last announced its earnings results on Monday, August 8th. The company reported $0.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The firm had revenue of $357.10 million for the quarter, compared to the consensus estimate of $324.11 million. During the same period in the previous year, the firm earned ($0.09) EPS. Opko Health’s revenue for the quarter was up 742.2% on a year-over-year basis. Analysts expect that Opko Health Inc. will post ($0.05) EPS for the current year.

A number of large investors have recently made changes to their positions in the company. ProShare Advisors LLC purchased a new stake in shares of Opko Health during the second quarter valued at approximately $100,000. Financial Architects Inc boosted its stake in shares of Opko Health by 21.5% in the second quarter. Financial Architects Inc now owns 10,950 shares of the company’s stock valued at $102,000 after buying an additional 1,940 shares during the last quarter. First Citizens Bank & Trust Co. purchased a new stake in shares of Opko Health during the second quarter valued at approximately $103,000. Williams Jones & Associates LLC boosted its stake in shares of Opko Health by 352.0% in the second quarter. Williams Jones & Associates LLC now owns 11,300 shares of the company’s stock valued at $106,000 after buying an additional 8,800 shares during the last quarter. Finally, Nuveen Fund Advisors LLC purchased a new stake in shares of Opko Health during the second quarter valued at approximately $131,000.

A number of brokerages have commented on OPK. Oppenheimer Holdings Inc. reiterated a “hold” rating on shares of Opko Health in a report on Tuesday, May 31st. Jefferies Group reiterated a “hold” rating and set a $10.00 target price (down previously from $11.00) on shares of Opko Health in a report on Friday, June 17th. Zacks Investment Research cut Opko Health from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Standpoint Research increased their target price on Opko Health from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 21st. Finally, Deutsche Bank AG lowered their target price on Opko Health from $11.00 to $10.00 and set a “hold” rating on the stock in a report on Thursday, June 16th. Five equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $13.20.

About Opko Health

OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.

5 Day Chart for NYSE:OPK

Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.